Related references
Note: Only part of the references are listed.Standards of medical care for type 2 diabetes in China 2019
Weiping Jia et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J. L. Heerspink et al.
LANCET (2019)
Long non-coding RNA MALAT1 expression in patients with gestational diabetes mellitus
Yisheng Zhang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis
Nektaria Papadopoulou-Marketou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy
Xue Li et al.
EXPERIMENTAL CELL RESEARCH (2017)
Wnt signaling and podocyte dysfunction in diabetic nephropathy
Madhura Bose et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
Alteration of oxidative stress and inflammatory cytokines induces apoptosis in diabetic nephropathy
Jibin Sha et al.
MOLECULAR MEDICINE REPORTS (2017)
The role of the complement system in diabetic nephropathy
Allan Flyvbjerg
NATURE REVIEWS NEPHROLOGY (2017)
LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy
Hong Yi et al.
CELL DEATH & DISEASE (2017)
Classification and Differential Diagnosis of Diabetic Nephropathy
Chenyang Qi et al.
JOURNAL OF DIABETES RESEARCH (2017)
Prevalence of Diabetes and Diabetic Nephropathy in a Large US Commercially Insured Pediatric Population, 2002-2013
Lin Li et al.
DIABETES CARE (2016)
MALAT1 long non-coding RNA in cancer
Rei Yoshimoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Alterations of Long Noncoding RNAs (lncRNA) Cause Pathogenetic Changes in Diabetic RetinopathyImage 4
Anu Thomas et al.
Canadian Journal of Diabetes (2016)
Trends in Chronic Kidney Disease in China
Luxia Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases
Eleni Arvaniti et al.
SCIENTIFIC REPORTS (2016)
Long non-coding MIAT mediates high glucose-induced renal tubular epithelial injury
Ling Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells
Prasanth Puthanveetil et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
End-stage renal disease and survival in people with diabetes: a national database linkage study
S. Bell et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2015)
Epidemiology and Risk Factors for Diabetic Kidney Disease
Valma Harjutsalo et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives
Cheol Whee Park
DIABETES & METABOLISM JOURNAL (2014)
Targeting long non-coding RNAs in cancers: Progress and prospects
Chi Han Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
MALAT1- a paradigm for long noncoding RNA function in cancer
Tony Gutschner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Reduction of Renal Superoxide Dismutase in Progressive Diabetic Nephropathy
Hiroki Fujita et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Double-edged action of SOD mimetic in diabetic nephropathy
Kensuke Asaba et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis
J Biederman et al.
KIDNEY INTERNATIONAL (2004)
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
P Ji et al.
ONCOGENE (2003)
Share Paper
